Dextromethorphan and guaifenesin syrup formulation
AssigneeGenexa Inc.
InventorsMax Spielberg, David Johnson
Life of this patent
Estimating the term…
Abstract
A stable pharmaceutical formulation or suspension has a pharmaceutical active agent, agave, and a dilutant. The formulation or suspension has viscosity suitable for drinking.
Claims19
A pharmaceutical syrup formulation for oral administration, composed of dextromethorphan HBr, guaifenesin, agave syrup, and a diluent, characterized in that the syrup's viscosity is within the range of 200 to 600 centipoise at approximately 22 degrees Celsius, and that the syrup is designed to be palatable.
A stable pharmaceutical syrup formulation for oral administration consisting of dextromethorphan HBr, guaifenesin, agave syrup, an acidic preservative, a flavoring agent, and a diluent, where the formulation exhibits a viscosity between 200 and 600 centipoise at around 22 degrees Celsius.
A stable and palatable pharmaceutical syrup formulation for oral administration, essentially comprising a therapeutically effective amount of dextromethorphan HBr, guaifenesin, agave syrup, citric extract, a flavoring agent, and a diluent, with a viscosity maintained between 200 and 600 centipoise at around 22 degrees Celsius.
Dependencies are inferred from the claim text.